So tell us what made you start, you know, Transformental and then a little bit about what you're up to these days.

Sure.

I mean, you were actually the first human that I told the story about Transformental 2 four years ago.

And I remember the conversation like it was yesterday because I I've been kind of brainstorming around kind of the challenges in the broader corporate ecosystem, really in healthcare, clinical delivery, life sciences, private equity, academia, publishing, the whole sphere of kind of how we take science and make it pragmatic, how people that are suffering from a wide range of conditions can live their best life, if you will.

And I've been doing it at that point when we first met for 24 years.

So it's not like it was like an initial consideration.

It was like there were some... benefits for sure, but there's just such a wide gap of knowledge translation.

So those are the two sort of tracks, whichever one you want to talk about first.